Significant Reduction of the Risk of Venous Thromboembolism in All Long-term Immobile Patients a Few Months After the Onset of Immobility
Overview
Authors
Affiliations
Prophylactic anticoagulation is a standard practice in patients with sudden lower limbs paralysis. Thromboprophylaxis is usually continued until the patient regains independent mobility. The duration of anticoagulation in long-term immobile patients is unknown. Spinal cord injury patients are the only population that was comprehensively studied and prophylactic anticoagulation is discontinued after 4 months as the risk of venous thromboembolism drops dramatically after 3-4 months. Development of muscle spasticity has been traditionally considered to be the reason for this low risk as lower limbs spasticity/spasms might be able to improve the calf muscle pump action. We are presenting the evidence from physiological studies of the lower limbs vascular system that cast doubt over this explanation and present an alternative hypothesis backed by several clinical circumstantial evidence suggesting that the vascular changes following long term lower limbs inactivity which are universal to all immobile patients is probably the main protecting factor. We suggest that prophylactic anticoagulation is necessary only on the first 4 months following the acute onset of immobility in all neurologically impaired immobile patients regardless of their muscle tone state.
Lowery A, Patel A, Ames R, Ramsey F, Slattery B, Pazionis T Int J Spine Surg. 2021; 15(3):562-569.
PMID: 33963036 PMC: 8176826. DOI: 10.14444/8076.
Mackiewicz-Milewska M, Cisowska-Adamiak M, Sakwinska K, Szymkuc-Bukowska I, Glowacka-Mrotek I Int J Environ Res Public Health. 2021; 18(8).
PMID: 33923442 PMC: 8073802. DOI: 10.3390/ijerph18084219.
Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).
Zhang X, Cai Q, Wang X, Liao K, Hu C, Chen H J Thromb Thrombolysis. 2021; 52(3):863-871.
PMID: 33674983 DOI: 10.1007/s11239-021-02415-5.
Mackiewicz-Milewska M, Kroszczynski A, Cisowska-Adamiak M, Pyskir J, Rosc D, Hagner W J Spinal Cord Med. 2020; 44(5):782-788.
PMID: 32011973 PMC: 8477962. DOI: 10.1080/10790268.2019.1708600.
Risk marker associations with venous thrombotic events: a cross-sectional analysis.
Golomb B, Chan V, Denenberg J, Koperski S, Criqui M BMJ Open. 2014; 4(3):e003208.
PMID: 24657882 PMC: 3963072. DOI: 10.1136/bmjopen-2013-003208.